FDA Endorses Canine Epilepsy and Lymphoma Drugs

WRITTEN BY TODAY’S VETERINARY BUSINESS IN JANUARY 2021   Two new oral medications — one for the control of seizures in dogs with idiopathic epilepsy and the other for the treatment of canine lymphoma — have received conditional approval from the U.S. Food and Drug Administration. The epilepsy drug, KBroVet-CA1 (potassium bromide chewable tablets), was developed by…